NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

iclight,



You repost the same nonsense repeatedly…

I believe that you’re drifting off way too far from Earth 🌎️ … You’re misinformed and need better sources of information. It is advisable to seek full-context credible sources and consult licensed oncologists.



Amid all of the misinformation and bad-faith disinformation pollution online, it is crucial that we refocus our attention beyond baseless social media posts to consider better sources…

For a reliable appraisal of the DCVax-L P3 trial, its design, and the significance of the resulting survival data, it is advisable to refer to the analyses of qualified physicians. One such analysis can be found on the JAMA Oncology website where the link to the independent peer review and supplementary materials are published.

JAMA Oncology is a peer-reviewed medical journal that us part of the Journal of the American Medical Association (JAMA) network, which is one of the most widely respected and influential medical journal publishers globally.

Being a peer-reviewed journal means that research articles submitted to JAMA Oncology undergo a thorough evaluation process by independent experts in the field before they are accepted for publication. This process helps ensure the quality, validity, and scientific rigor of the research presented in the journal.

Researchers, healthcare professionals, and the medical community rely on publications like JAMA Oncology for up-to-date and credible information in the field of oncology.

https://ceoworld.biz/2022/04/05/top-5-medical-journals-in-the-world-everyone-should-know-about/

This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated with improved survival in both newly diagnosed & recurrent glioblastoma compared with matched controls who received SOC treatment. https://t.co/Uso7Pkh1Kt

— JAMA Oncology (@JAMAOnc) February 15, 2023

https://finance.yahoo.com/news/northwest-biotherapeutics-announces-dr-linda-140000962.html

https://www.jci.org/articles/view/169314

https://www.uclahealth.org/news/fda-approval-brain-cancer-alzheimers

https://hotb.org/wp-content/uploads/2022/05/spore-article-for-donors-4.18.22.pdf

https://www.uclahealth.org/news/brain-cancer-discovery-clinical-trials

Our team just met with the @NorthwestBio team to learn about #DCVax and had the pleasure of speaking with longterm DCVax patients. An honor and a privilege. #endbraincancer #sno2023 pic.twitter.com/dw3X76DBru

— EndBrainCancer Initiative (@EndBrainCancer) November 19, 2023